CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Open-market buy Chief Executive Officer bought 91,743 shares at $0.96 ($88,073)
- 4 Open-market buy Chief Innovation/Tech Officer bought 45,871 shares at $0.96 ($44,036)
- 4 Open-market buy SVP-Bus. Process & Info. Tech. bought 2,293 shares at $0.96 ($2,201)
- 4 Open-market buy General Counsel bought 13,761 shares at $0.96 ($13,211)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 19 of 35 · 690 filings